Longitudinal structural changes in ALS: a three time-point imaging study of white and gray matter degeneration
- PMID: 29214883
- DOI: 10.1080/21678421.2017.1407795
Longitudinal structural changes in ALS: a three time-point imaging study of white and gray matter degeneration
Abstract
Background: Cross-sectional imaging studies offer valuable pathological insights into the neurodegenerative changes of amyotrophic lateral sclerosis. However, clinical trials urgently require sensitive monitoring markers that can detect subtle progressive changes over relatively short periods of time. We have conducted a three time-point longitudinal study to explore anatomical patterns of disease spread and to determine whether MRI metrics capture longitudinal changes over four and eight-month intervals.
Methods: Thirty-two ALS patients were enrolled into a multiparametric imaging study to evaluate progressive cortical thickness, grey matter density and white matter alterations. Whole-brain and region-of-interest analyses were conducted in the precentral gyrus, corticospinal tracts, corpus callosum and cerebellum. Additionally, pre-symptomatic changes were explored in patients with no bulbar or lower limb disability.
Results: Our findings suggest that considerable white matter degeneration can be detected early in the course of the disease which shows limited progression over time, whereas grey matter pathology is relatively limited at baseline and exhibits relentless progression. Moreover, progressive presymptomatic structural changes can be identified in the bulbar and lower limb representations of the precentral gyrus.
Conclusions: Our longitudinal imaging study confirms that MRI metrics readily capture progressive changes in ALS. Our data also indicate that white matter metrics are of potential use as diagnostic markers, and grey matter measures may be superior as monitoring biomarkers. One of the most interesting findings of our study is the gradually progressive cerebellar grey matter degeneration throughout the three time-points.
Keywords: Amyotrophic lateral sclerosis; longitudinal study; motor neuron disease; multimodal imaging; presymptomatic change.
Similar articles
-
The two-year progression of structural and functional cerebral MRI in amyotrophic lateral sclerosis.Neuroimage Clin. 2017 Dec 18;17:953-961. doi: 10.1016/j.nicl.2017.12.025. eCollection 2018. Neuroimage Clin. 2017. PMID: 29321969 Free PMC article.
-
Structural and diffusion imaging versus clinical assessment to monitor amyotrophic lateral sclerosis.Neuroimage Clin. 2016 Mar 16;11:408-414. doi: 10.1016/j.nicl.2016.03.011. eCollection 2016. Neuroimage Clin. 2016. PMID: 27104135 Free PMC article.
-
Brainstem pathology in amyotrophic lateral sclerosis and primary lateral sclerosis: A longitudinal neuroimaging study.Neuroimage Clin. 2019;24:102054. doi: 10.1016/j.nicl.2019.102054. Epub 2019 Oct 24. Neuroimage Clin. 2019. PMID: 31711033 Free PMC article.
-
Neuroimaging to investigate multisystem involvement and provide biomarkers in amyotrophic lateral sclerosis.Biomed Res Int. 2014;2014:467560. doi: 10.1155/2014/467560. Epub 2014 Apr 17. Biomed Res Int. 2014. PMID: 24949452 Free PMC article. Review.
-
Biomarkers for C9orf7-ALS in Symptomatic and Pre-symptomatic Patients: State-of-the-art in the New Era of Clinical Trials.J Neuromuscul Dis. 2022;9(1):25-37. doi: 10.3233/JND-210754. J Neuromuscul Dis. 2022. PMID: 34864683 Free PMC article. Review.
Cited by
-
Mismatch between clinically defined classification of ALS stage and the burden of cerebral pathology.J Neurol. 2024 Jan 28. doi: 10.1007/s00415-024-12190-x. Online ahead of print. J Neurol. 2024. PMID: 38282082
-
Impact of follow ups, time interval and study duration in diffusion & myelin MRI clinical study in MS.Neuroimage Clin. 2023;40:103529. doi: 10.1016/j.nicl.2023.103529. Epub 2023 Oct 12. Neuroimage Clin. 2023. PMID: 37857232 Free PMC article.
-
Hippocampal Metabolic Alterations in Amyotrophic Lateral Sclerosis: A Magnetic Resonance Spectroscopy Study.Life (Basel). 2023 Feb 17;13(2):571. doi: 10.3390/life13020571. Life (Basel). 2023. PMID: 36836928 Free PMC article.
-
Longitudinal monitoring of amyotrophic lateral sclerosis by diffusion tensor imaging: Power calculations for group studies.Front Neurosci. 2022 Aug 10;16:929151. doi: 10.3389/fnins.2022.929151. eCollection 2022. Front Neurosci. 2022. PMID: 36117627 Free PMC article.
-
Evidence of cerebellar TDP-43 loss of function in FTLD-TDP.Acta Neuropathol Commun. 2022 Jul 25;10(1):107. doi: 10.1186/s40478-022-01408-6. Acta Neuropathol Commun. 2022. PMID: 35879741 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
